The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer

Abstract Objectives Women with advanced ovarian cancer are treated with chemotherapy either before (neoadjuvant) or after surgery (primary debulking). The goal is to leave no residual disease post-surgery; for women treated with primary debulking surgery this has been associated with an improvement...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2014-09, Vol.134 (3), p.462-467
Hauptverfasser:	Rosen, Barry, Laframboise, Stephane, Ferguson, Sarah, Dodge, Jason, Bernardini, Marcus, Murphy, Joan, Segev, Yakir, Sun, Ping, Narod, Steven A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Chemotherapy, Adjuvant Female Gynecologic Surgical Procedures - methods Hematology, Oncology and Palliative Medicine Humans Intraperitoneal chemotherapy Middle Aged Neoadjuvant chemotherapy Neoadjuvant Therapy Neoplasm Staging Neoplasm, Residual Obstetrics and Gynecology Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - mortality Ovarian Neoplasms - pathology Ovarian Neoplasms - surgery Postoperative Period Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!